Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support

Bone Marrow Transplantation

Volumn 28, Issue 11, 2001, Pages 1061-1066

  Ballen, K K ^a   Hesketh, A M ^b   Heyes, C ^b   Becker, P S ^b   Emmons, R V B ^a   Fogarty, K ^b   LaPointe, J ^b   Liu, Q ^a   Hsieh, C C ^b   Hesketh, P J ^b  

^a University of Massachusetts   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Nausea

Indexed keywords

ANTIEMETIC AGENT; DEXAMETHASONE; DIPHENHYDRAMINE; GRANISETRON; LORAZEPAM; ONDANSETRON; PERPHENAZINE;

ADULT; AGED; ALLOGRAFT; ARTICLE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; EVALUATION; EXPERIENCE; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MOTION SICKNESS; MULTIVARIATE ANALYSIS; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; AGED; ANTIEMETICS; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VOMITING;

EID: 0035666946     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703280     Document Type: Article

References (31)

1. Marrow transplantation for the treatment of chronic myelogenous leukemia
2. Bone marrow transplantation for genetic disease
3. Marrow transplantation in patients with advanced thalassemia
4. Histocompatibility
5. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia
6. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation
7. Outcomes among 562 recipients of placental blood transplants from unrelated donors
8. On the receiving end: Patient perception of the side-effects of cancer chemotherapy
9. On the receiving end V: Patient perceptions of the side effects of the cancer chemotherapy in 1993
10. Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin
11. Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy
12. Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy
13. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplaitin-induced emesis in patients with cancer
14. Single-dose ondansetron for prevention of acute cisplatin-induced emesis: Analysis of efficacy and prognostic factors
15. Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting
16. Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents
17. Antiemetic therapy for high-dose chemotherapy with transplantation: Report of a retrospective analysis of a 5-HT3 regimen and literature review
18. Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines
19. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation
20. An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantation
21. Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation
22. A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation
23. The antiemetic efficacy of tropisetron plus dexamethasone in patients treated with high-dose chemotherapy and stem cell transplantation
24. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation
25. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: A meta-analysis of randomized evidence
26. Antiemetic profile of a non-peptide neurokinin NK1 receptor antagonist CP-99, 994 in ferrets
27. The anti-emetic effects of CP-99, 994 in the ferret and the dog: Role of the NK1 receptor
28. Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99, 994
29. Reduction of cisplatin-induced emesis by selective neurokinin-1-receptor antagonist
30. Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11, 974 in the control of cisplatin-induced emesis